MSI is BHBIA certified

By editor | Published: May 21, 2010

We are pleased to announce that as of May 2010 all members of the MSI research team have been certified under the the latest ABPI/BHBIA adverse events guidelines.

These guideline ensure that details of any adverse events mentioned during research as properly fed back to the pharma company and/or regulatory authorities using the MHRA’s ‘yellow card’ system.

A copy of the current guidelines can be found here

This entry was posted in All News, Marketing Sciences News, News. Bookmark the permalink. Post a comment or leave a trackback: Trackback URL.

One Trackback

  1. By Rob Rasner on May 5, 2011 at 2:16 pm

    Rob Rasner Says It’s An Incredible Article Cool!…

    Great story; thought I might insert some not related data, although still worthwhile looking….

Post a Comment

You must be logged in to post a comment.

  • Recent Updates

    • Interactive Article – Building Brands Fit For The Future

      MSI Have published the first of a series of interactive articles – Building Read More…

    • Cello Group plc Partner Appointment

      Cello Group plc (AIM: CLL, “Cello” or “the Group”) is pleased to announce Read More…

  • Recent Articles

    • Building Brands Fit For The Future

      Over the years, many individuals and companies have extolled the virtues of building Read More…

    • Small Pharma: What does the future hold for the small, specialised Pharma Company?

      We are all aware that Big Pharma has been seeking to successfully re-invent Read More…